Evaluation of the Efficacy of the Composite WM Formula in Body Weight Change

Launched by TCI CO., LTD. · Jul 30, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a dietary supplement called the WM Formula to see if it can help improve body weight and overall health in adults with obesity. Researchers want to find out if this supplement can positively affect blood sugar levels, cholesterol, body fat, and the balance of good bacteria in the gut. The goal is to understand whether taking this formula can support healthier body weight and metabolic health.

Adults 18 years and older with a higher body fat percentage (30% or more for women, 25% or more for men) may be eligible to join, as long as they are not pregnant or breastfeeding and agree to use birth control during the study. People who have recently used certain weight loss or blood sugar medications, have certain health conditions like digestive disorders or allergies to the supplement, or have had major surgeries may not qualify. Participants will be asked to take the supplement and have their health monitored to see how their body weight and other health markers change over time. This study has not started recruiting yet, but it aims to provide helpful information for people looking for safe ways to manage obesity.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 18 years or older who are willing to sign the informed consent form.
• • Body fat percentage: ≥30% for females and ≥25% for males.
• • Non-pregnant and non-lactating women who agree to use physical contraceptive methods (e.g., condoms, intrauterine devices) throughout the study period.
• Exclusion Criteria:
• • Use of GLP-1 receptor agonists approved in Taiwan (e.g., liraglutide, semaglutide, dulaglutide), blood glucose-regulating medications, weight loss-related drugs or functional foods, probiotics, or gastrointestinal health-related supplements or medications within 30 days prior to the start of the study.
• • History of chronic gastrointestinal disorders, seizure disorders or epilepsy, hepatic or renal diseases, malignancies, endocrine disorders, psychiatric illnesses, alcohol or drug abuse, or other major organic diseases based on medical history.
• • History of gastrointestinal surgery, organ transplantation, or other major surgeries.
• • History of hypoglycemia.
• • Known lactose intolerance.
• • Chronic diarrhea.
• • Acute gastroenteritis within 2 weeks prior to study initiation.
• • Known allergy to any ingredient in the investigational product.
• • Employees or immediate family members of TCI Co., Ltd.